Respimat

GPTKB entity

Statements (58)
Predicate Object
gptkbp:instance_of gptkb:superhero
gptkbp:approves gptkb:2014
gptkb:FDA
gptkbp:care_instructions shake before use
prime before first use
gptkbp:clinical_trial maintenance therapy
demonstrated efficacy
well tolerated
long-term management
rescue therapy
reduced exacerbations
showed improved lung function
gptkbp:delivers gptkb:drug
gptkbp:education requires training
important for proper use
gptkbp:features lightweight design
ergonomic grip
dose indicator
easy-to-read instructions
gptkbp:feedback generally positive
improved adherence
preferred over traditional inhalers
satisfaction with delivery system
gptkbp:formulation aerosol
https://www.w3.org/2000/01/rdf-schema#label Respimat
gptkbp:ingredients olodaterol
tiotropium
gptkbp:invention patented
gptkbp:is_available_in multiple flavors
various strengths
gptkbp:is_compared_to nebulizers
metered-dose inhalers
gptkbp:is_designed_for easy handling
consistent dosing
gptkbp:is_used_for gptkb:asthma
chronic obstructive pulmonary disease
gptkbp:maintenance clean regularly
replace cartridge as needed
gptkbp:manager inhalation
gptkbp:manufacturer gptkb:Boehringer_Ingelheim
gptkbp:marketed_as Respimat Soft Mist Inhaler
gptkbp:population gptkb:Person
adults
gptkbp:provides_information_on used in combination therapy
recommended for COPD
recommended for asthma
used in stepwise approach
gptkbp:regulatory_compliance approved for use in multiple countries
gptkbp:side_effect headache
nausea
cough
dry mouth
throat irritation
gptkbp:storage room temperature
protected from light
gptkbp:technology soft mist inhaler
gptkbp:bfsParent gptkb:Combivent_Respimat
gptkbp:bfsLayer 6